References in periodicals archive ?
coli O157:H7, Shigella dysenteriae, Pseudomonas aeruginosa, Salmonella typhimurium, Salmonella paratiphi C and Klebsiella pneumonia strains were grown in LB medium.
Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids.
The MMSS was shown to exhibit good antibacterial activity when tested against Escherichia coli, Shigella dysenteriae, and Pseudomonas aeruginosa and also supported to the previous study (45).
The lead conjugates in development are vaccines directed against Shigella dysenteriae, to prevent serious intestinal infections, and hospital acquired Staphylococcus aureus.
However the Gram negative bacterium Shigella dysenteriae was inhibited with SA-PES SA-ES SA-EAS (MIC= 250 g/disc) and SA-AS (MIC= 62.
Molecular characterization of the SHV-11 P-lactamase of Shigella dysenteriae.
An outbreak of Shigella dysenteriae type 2 among laboratory workers due to intentional food contamination.
Study to Evaluate Safety, Reactogenicity and Immunogenicity of Vaccine Against Shigella dysenteriae
Guidelines for the control of shigellosis, including epidemics of Shigella dysenteriae type 1.
Salmonella typhi ATCC 14028, Salmonella para typhi A, Salmonella para typhi B, Pseudomonas aeruginosa ATCC 902, Pseudomonas aeruginosa, Escherichia coli ATCC 8739, Escherichia coli (MDR), Escherichia coli, Shigella dysenteriae, Shigella flexneri, Shigella
coli (EHEC), and Shigella dysenteriae serotype 1 (S.